About Galipea
Galipea is a Healthcare company. Pharmaceutical product manufacturing and marketing in India. Its Indian entity Galipea Molecules Private Limited reported revenue of ₹68.2 Lakh. Galipea offers products and services including Syrups and Tablets. Its focus areas include Consumer Goods, Over-the-Counter Drugs, Health Products and Pharmaceuticals.
Company details
Galipea Molecules Pvt. Ltd. was established in June 2019 and registered with the Registrar of Companies in Delhi, operating as a non-government entity limited by shares. Premium quality pharmaceutical products, including syrups, tablets, capsules, injections, ointments, and sachets, are manufactured by the company to meet WHO-GMP standards. Innovative formulations derived from rich, natural ingredients are utilized to advance healthcare solutions in Indias pharmaceutical industry, with a commitment to enhancing patient outcomes through core product development.
- SectorsHealthcare
- Email••••••••
- Social LinkedIn Facebook
- Legal Name Galipea Molecules Pvt. Ltd
- Date of Incorporation 18 Jun, 2019
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹68.2 Lakh
FY 2024 · +112% YoY
- Indian entity net loss-₹13.2 Lakh
FY 2024 · -19% margin
- Indian entity EBITDA-₹12.9 Lakh
FY 2024 · -19% margin
Associated legal entities of Galipea
Galipea operates through Galipea Molecules Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Galipea Molecules Private Limited CIN U24299DL2019PTC351484 | Active | 18 Jun 2019 | New Delhi, Delhi | ₹0.7 Cr | 2 | View details |
Products & Services of Galipea
Galipea offers a comprehensive portfolio of products and services, including Syrups and Tablets.
Syrups are manufactured to meet healthcare needs using innovative formulations and high-quality standards.
Tablets are produced with natural ingredients and WHO-GMP certified processes for effective healthcare solutions.
Board of directors of Galipea Molecules Private Limited (Galipea)
Galipea Molecules Private Limited is the primary company behind Galipea. The board of Galipea Molecules Private Limited currently have 2 directors; the longest-serving is Rameshwar Kumar, appointed in 2019. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rameshwar Kumar DIN 07473078 | Director | 18 Jun 2019 | 7 yrs 4 mo | Galipea Molecules Private Limited |
| Srishti Shaumya DIN 07473082 | Director | 18 Feb 2022 | 4 yrs 8 mo | Galipea Molecules Private Limited |
Financials of Galipea
Figures of Galipea Molecules Private Limited, the primary company behind Galipea, for FY 2024. Revenue was ₹68.2 Lakh (+112% year on year). Net loss was -₹13.2 Lakh (-19% margin). EBITDA was -₹12.9 Lakh (-19% margin). Revenue has grown at a compounded annual rate of +45% over three years.
- ₹68.2 LakhRevenue · FY 2024 · +112% YoY
- -₹13.2 LakhNet loss · -19% margin
- -₹12.9 LakhEBITDA · -19% margin
- ₹1 LakhPaid-up capital
- +45%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Galipea Molecules Private Limited are on its company page.
Detailed financial statements for Galipea
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Galipea
The primary company behind Galipea, Galipea Molecules Private Limited, reported revenue of ₹68.2 Lakh for FY 2024, up 112% year on year.
Galipea Molecules Pvt. Ltd. was established in June 2019 and registered with the Registrar of Companies in Delhi, operating as a non-government entity limited by shares. Premium quality pharmaceutical products, including syrups, tablets, capsules, injections, ointments, and sachets, are manufactured by the company to meet WHO-GMP standards. Innovative formulations derived from rich, natural ingredients are utilized to advance healthcare solutions in Indias pharmaceutical industry, with a commitment to enhancing patient outcomes through core product development.
Galipea offers Syrups and Tablets.
Galipea operates through Galipea Molecules Private Limited.
The legal entities of Galipea currently have 2 directors, including Rameshwar Kumar, Srishti Shaumya.